233 related articles for article (PubMed ID: 21621871)
21. Prognostic Value of p16 Protein in Patients With Surgically Treated Non-small Cell Lung Cancer; Relationship With Ki-67 and PD-L1.
Pezzuto A; Cappuzzo F; D'Arcangelo M; Ciccozzi M; Navarini L; Guerrini S; Ricci A; D'Ascanio M; Carico E
Anticancer Res; 2020 Feb; 40(2):983-990. PubMed ID: 32014943
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Qian HH; Xu TS; Cai XQ; Ji TL; Guo HX
Clin Chim Acta; 2015 Dec; 451(Pt B):208-14. PubMed ID: 25661085
[TBL] [Abstract][Full Text] [Related]
23. The role of cyclin D1 expression and patient's survival in non-small-cell lung cancer: a systematic review with meta-analysis.
Zhang LQ; Jiang F; Xu L; Wang J; Bai JL; Yin R; Wu YQ; Meng LJ
Clin Lung Cancer; 2012 May; 13(3):188-95. PubMed ID: 22133292
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.
Zheng CL; Qiu C; Shen MX; Qu X; Zhang TH; Zhang JH; Du JJ
Asian Pac J Cancer Prev; 2015; 16(5):1881-95. PubMed ID: 25773840
[TBL] [Abstract][Full Text] [Related]
25. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
26. Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance.
Millares L; Barreiro E; Cortes R; Martinez-Romero A; Balcells C; Cascante M; Enguita AB; Alvarez C; Rami-Porta R; Sánchez de Cos J; Seijo L; Monsó E;
Lung Cancer; 2018 Aug; 122():124-130. PubMed ID: 30032820
[TBL] [Abstract][Full Text] [Related]
27. p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung.
Huang CI; Taki T; Higashiyama M; Kohno N; Miyake M
Br J Cancer; 2000 Jan; 82(2):374-80. PubMed ID: 10646891
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.
Liang Y; Guo S; Zhou Q
Tumour Biol; 2014 Apr; 35(4):3717-24. PubMed ID: 24338766
[TBL] [Abstract][Full Text] [Related]
30. Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
Shiran I; Heller E; Jessel S; Kamer I; Daniel-Meshulam I; Navon R; Urban D; Onn A; Bar J
Clin Lung Cancer; 2017 May; 18(3):316-323.e1. PubMed ID: 28237243
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
[TBL] [Abstract][Full Text] [Related]
32. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.
Jiang H; Zhao W; Shao W
Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis.
Chen E; Zeng Z; Bai B; Zhu J; Song Z
Oncotarget; 2016 Aug; 7(35):56526-56539. PubMed ID: 27489355
[TBL] [Abstract][Full Text] [Related]
37. The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis.
Zhao J; Shi X; Wang T; Ying C; He S; Chen Y
Cell Physiol Biochem; 2017; 43(2):697-704. PubMed ID: 28946136
[TBL] [Abstract][Full Text] [Related]
38. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas.
Sterlacci W; Tzankov A; Veits L; Zelger B; Bihl MP; Foerster A; Augustin F; Fiegl M; Savic S
J Thorac Oncol; 2011 Oct; 6(10):1649-57. PubMed ID: 21857254
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study).
Toffart AC; Timsit JF; Couraud S; Merle P; Moro-Sibilot D; Perol M; Mastroianni B; Souquet PJ; Girard N; Jeannin G; Romand P; Chatellain P; Vesin A; Brambilla C; Brambilla E
Lung Cancer; 2014 Feb; 83(2):182-8. PubMed ID: 24388706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
